AI heart scans could replace MRI for chemo patients

NCT ID NCT07093918

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will test whether AI-enhanced 3D and 2D echocardiography (heart ultrasound) can detect chemotherapy-related heart damage as accurately as cardiac MRI. Researchers will compare these new imaging methods with standard ultrasound and MRI in 120 adults who have received potentially heart-damaging chemotherapy. If the AI methods prove reliable, they could offer a faster, cheaper, and more accessible way to monitor heart health during cancer treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
V-echo and L-echo (AI-enhanced 3D and 2D echocardiography imaging systems)
What this could lead to
If successful, this could provide a quicker, more accessible way to monitor heart health in chemotherapy patients, reducing the need for costly MRI scans.
What could go wrong
This is an early-stage diagnostic study with only 120 participants. The AI methods may not prove accurate enough to replace MRI, and results may not apply to all patient groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer Cardiotoxicity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.